Business Description
Novartis AG
NAICS : 325412
ISIN : US66987V1098
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.69 | |||||
Debt-to-EBITDA | 1.47 | |||||
Interest Coverage | 12.02 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.14 | |||||
Beneish M-Score | -2.56 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 4.3 | |||||
3-Year EPS without NRI Growth Rate | 4.6 | |||||
3-Year FCF Growth Rate | 4.2 | |||||
3-Year Book Growth Rate | -3.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 8.83 | |||||
Future 3-5Y Total Revenue Growth Rate | 1.95 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.45 | |||||
9-Day RSI | 58.61 | |||||
14-Day RSI | 54.52 | |||||
6-1 Month Momentum % | 1.03 | |||||
12-1 Month Momentum % | -1.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.9 | |||||
Quick Ratio | 0.71 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 181.15 | |||||
Days Sales Outstanding | 58.85 | |||||
Days Payable | 128.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.88 | |||||
Dividend Payout Ratio | 0.85 | |||||
3-Year Dividend Growth Rate | 3.8 | |||||
Forward Dividend Yield % | 3.88 | |||||
5-Year Yield-on-Cost % | 4.19 | |||||
3-Year Average Share Buyback Ratio | 3.2 | |||||
Shareholder Yield % | 9.22 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.79 | |||||
Operating Margin % | 21.28 | |||||
Net Margin % | 30.18 | |||||
FCF Margin % | 20.33 | |||||
ROE % | 32.69 | |||||
ROA % | 14.08 | |||||
ROIC % | 10.29 | |||||
ROC (Joel Greenblatt) % | 93.98 | |||||
ROCE % | 14.58 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 13.29 | |||||
Forward PE Ratio | 13.61 | |||||
PE Ratio without NRI | 22.05 | |||||
Shiller PE Ratio | 17.12 | |||||
Price-to-Owner-Earnings | 10.23 | |||||
PS Ratio | 4.16 | |||||
PB Ratio | 5.12 | |||||
Price-to-Free-Cash-Flow | 20.32 | |||||
Price-to-Operating-Cash-Flow | 14.98 | |||||
EV-to-EBIT | 20.39 | |||||
EV-to-Forward-EBIT | 14.09 | |||||
EV-to-EBITDA | 11.77 | |||||
EV-to-Forward-EBITDA | 11.25 | |||||
EV-to-Revenue | 4.37 | |||||
EV-to-Forward-Revenue | 4.36 | |||||
EV-to-FCF | 22.05 | |||||
Price-to-Projected-FCF | 1.39 | |||||
Price-to-Median-PS-Value | 1.09 | |||||
Earnings Yield (Greenblatt) % | 4.9 | |||||
FCF Yield % | 5.14 | |||||
Forward Rate of Return (Yacktman) % | 10.2 |